Simpson Thacher & Bartlett and Lee & Li have advised a consortium led by KKR & Co on its $1.56 billion acquisition of Taipei-listed LCY Chemical, which was represented by Baker McKenzie.
This was the U.S. private equity firm’s first deal in Taiwan in more than a decade, and the largest private equity-backed transaction in the island, according to Reuters.
According to Reuters, KKR is leading a group of investors including LCY’s employees and family members of its founders. Upon closing, KKR will hold a majority and controlling interest in the chemicals company, which will be delisted from the Taiwan Stock Exchange.
The Simpson Thacher & Bartlett team was led by M&A partner Ian Ho, who was supported by partners Chris Lin, Makiko Harunari and Katharine Moir.
The Baker McKenzie team was led by partner Mark Tu.
Earlier this year, Simpson Thacher advised KKR on its first-ever sale of Japanese yen-denominated bonds, which raised 40.3 billion yen ($377 million).
To contact the editorial team, please email ALBEditor@thomsonreuters.com.